Tenaya Therapeutics announces common stock, warrants offering

Tenaya Therapeutics (TNYA) announced that it intends to offer and sell units consisting of common stock and Series A warrants and Series B warrants, each to purchase shares of common stock. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Leerink Partners and Piper Sandler are acting as joint bookrunning managers for the proposed offering.